Kiribati vs New Zealand: Treatment success rate for patients treated for MDR-TB
Kiribati
100.0%
in 2022
New Zealand
100.0%
in 2022
Kiribati rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Kiribati
- New Zealand
How they compare
Kiribati currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
Across all 6 years both countries report, New Zealand has been ahead every year.
Kiribati ranks 1st and New Zealand ranks 1st of 163 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 91.5% | 100.0% | 8.5% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kiribati or New Zealand?
- Kiribati, at 100.0% against 100.0% in New Zealand as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kiribati and New Zealand?
- 0.0%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and New Zealand?
- 6 years are reported by both, from 2015 to 2022.
- How do Kiribati and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Kiribati ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.